Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Design and development of purine-scaffold inhibitors of the heat shock protein 90
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2006)

    Fulltext@MSK | Save
  • The inhibitory Fc gamma-receptor IIB (CD32B) is highly expressed on clonal plasma cells from patients with systemic light-chain (AL) amyloidosis and provides a target for monoclonal antibody therapy
    Meeting Abstract

    Zhou, P.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Fleisher, M.; Young, J.; Boruchov, A.; Comenzo, R. L.
    Amyloid (2006)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP for mantle cell lymphoma demonstrates RIT can induce molecular remissions
    Meeting Abstract

    Zelenetz, A. D.; Noy, A.; Pandit-Taskar, N.; Scordo, M.; Rijo, I.; Zhou, Y.; O'Donoghue, J. A.; Divgi, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Adoptive transfer of in vitro generated T cell precursors improves T cell reconstitution and mediates graft-versus-tumor activity without graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients
    Meeting Abstract

    Zakrzewski, J. L.; Kochman, A. A.; Lu, S. X.; Terwey, T.; Kim, T. D.; Hubbard, V. M.; Muriglan, S. J.; Suh, D.; Cabrera-Perez, J.; Heller, G.; more...
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Human natural killer cells achieve tolerance by preferentially endowing functional competence to inhibitory killer Ig-like receptors specific for self-HLA class I
    Meeting Abstract

    Yu, J.; Pinto-Agnello, C.; Chewning, J.; Hsu, K. C.
    Blood (2006)

    Fulltext@MSK | Save
  • Majority of transformed lymphomas have high SUVs on PET scanning similar to diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Weissler, M.; Noy, A.; Schoder, H.; Gonen, M.; Yeung, H.
    Blood (2006)

    Fulltext@MSK | Save
  • Validation of flow cytometric measurements of NK cytotoxicity against chromium release assay for use in clinical monitoring of immune function
    Meeting Abstract

    Smith, K.; Heller, G.; Maslak, P.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of rituximab for the prevention of Epstein Barr virus B cell lymphoproliferative disorder (EBV-LPD) following T cell depleted (TCD) unrela ted or HLA-mismatched related hematopoietic stem cell transplantation
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Jakubowski, A.; Young, J. W.; Prockop, S.; Perales, M. A.; O'Reilly, R. J.; Papadopoulos, E. B.
    Blood (2006)

    Fulltext@MSK | Save
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Outcomes following thoracoabdominal resection for neuroblastoma
    Meeting Abstract

    Ross, S. L.; Greenwald, B.; Howell, J.; Pon, S.; Rutigliano, D.; Laquaglia, M.
    Critical Care Medicine (2006)

    Fulltext@MSK | Save